Barbara Weber has been appointed President and CEO of Tango Therapeutics.
3 reports, 1 independent
Updated Aug 1
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Barbara Weber has been appointed President and CEO of Tango Therapeutics.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Tango Therapeutics (United States)
company in Cambridge, United States
Nothing else this week.
-
Barbara Weber
professor at DTU
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireTango Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference BOSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Barbara Weber
- GlobeNewswireTango Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights – First patient dosed in combination trial of TNG462 and Revolution Medicines RAS(ON) inhibitors – –